The Daily Differential — Monday, April 20, 2026

2 of 5

Hypoglycemic Agents Toxicity and Poisoning

Insulin and oral hypoglycemic overdoses can cause profound, recurrent hypoglycemia with neurologic injury, especially with long-acting or sustained-release...

At the Bedside

Agents to know:
Insulin: rapid-, short-, intermediate-, long-acting; intentional overdose can produce prolonged hypoglycemia.
Sulfonylureas: glyburide, glipizide, glimepiride, chlorpropamide; stimulate endogenous insulin release and often cause recurrent hypoglycemia.
Meglitinides: repaglinide, nateglinide; similar but usually shorter acting.
Presentation: diaphoresis, tremor, palpitations, confusion, seizure, coma; in young children, any unexplained altered mental status or seizure warrants glucose check.
Workup:
Point-of-care glucose immediately.
BMP, Mg, phosphate if severe/prolonged.
Consider co-ingestants, intentional self-harm, renal failure, sulfonylurea exposure in children.
If unclear hypoglycemia etiology: insulin, C-peptide, sulfonylurea screen may help but should not delay treatment.
Initial management:
If awake and able to swallow: oral glucose.
If altered: IV dextrose bolus.
Recheck glucose frequently; recurrent hypoglycemia is common.
For sulfonylurea toxicity, dextrose alone can worsen insulin release, so add octreotide early.
Definitive therapy:
Octreotide is the antidote for sulfonylurea-induced hypoglycemia and reduces rebound episodes.
Large insulin overdoses may require prolonged dextrose infusion and electrolyte monitoring (especially potassium).
Disposition:
Admit if recurrent hypoglycemia, long-acting insulin, sulfonylurea ingestion, suicide attempt, or need for infusion.
Some short-acting insulin exposures with stable sugars after observation may be discharged per poison center guidance.

Classic Presentation

A 4-year-old is brought in after accidental ingestion of grandmother’s diabetes pills. He is sweaty, lethargic, and has a glucose of 32 mg/dL. He receives IV dextrose, but his glucose drops again 45 minutes later. Sulfonylurea exposure is suspected, poison center is consulted, and octreotide is started to prevent recurrent insulin-driven hypoglycemia.

Study Directive

Memorize the distinction: insulin overdose = glucose replacement, sulfonylurea overdose = glucose + octreotide.
Practice a hypoglycemia algorithm from memory: POC glucose → IV dextrose → repeat checks → octreotide if recurrent.
Review duration differences among common insulin types and which ones need prolonged observation.
Create a one-minute script for calling poison center about a sulfonylurea ingestion.
Drill pediatric dextrose dosing and the red flag that any unexplained seizure in a toddler is a glucose check.

Key Medications

Dextrose IV
D50W 25 g IV (50 mL) adult bolus is common; many centers prefer D10W titration/infusion to reduce extravasation risk.
Pediatric: D10W 2.5 mL/kg IV.
Octreotide
Adult: 50–100 mcg SQ or IV q6h commonly used; some protocols use infusion.
Variability exists by protocol and severity; check poison center/institutional guidance.
Pediatric: often 1–2 mcg/kg/dose (verify local protocol).
Glucagon
1 mg IM/IV/IN if no IV access; less reliable in malnourished/alcohol-related cases and may be ineffective in sulfonylurea toxicity if glycogen stores are depleted.
Activated charcoal
If very early after ingestion and airway protected; use depends on substance and timing.

High-Yield Pearls

If hypoglycemia keeps returning after dextrose, think sulfonylurea until proven otherwise.
Dextrose can transiently fix the number but not the physiology in sulfonylurea poisoning.
Large insulin overdoses can cause hypokalemia from intracellular shift; monitor and replete carefully.

Board Question

A 56-year-old woman is found confused after ingesting an unknown number of glipizide tablets. Her glucose is 38 mg/dL, and it rises after IV dextrose but falls again an hour later. What medication best prevents recurrence?

ANaloxone
BAtropine
COctreotide
DFlumazenil

Reveal answer

Correct: C

Octreotide Sulfonylureas cause endogenous insulin release, leading to recurrent hypoglycemia after dextrose. Octreotide suppresses insulin secretion and is the key therapy to prevent rebound episodes. Naloxone, atropine, and flumazenil do not treat this mechanism.

3 of 5

Methemoglobinemia

Methemoglobinemia causes functional hypoxia that can be missed if you rely on PaO2 alone. Severe cases can rapidly progress to tissue hypoxia, neurologic...

At the Bedside

Causes: topical anesthetics (benzocaine, lidocaine in excess), dapsone, nitrates/nitrites, aniline dyes, primaquine, sulfonamides, local anesthetic sprays, well water in infants.
Presentation: cyanosis out of proportion to respiratory status, headache, dyspnea, fatigue, tachycardia, chocolate-brown blood.
Key clues:
Pulse ox often sticks around ~85% and does not improve much with oxygen.
ABG PaO2 may be normal because dissolved oxygen is okay, but oxygen delivery is impaired.
Co-oximetry is diagnostic.
Workup:
Co-oximetry methemoglobin level.
ECG, lactate, BMP as needed; evaluate for co-ingestions or hemolysis.
Initial management:
Stop offending agent.
High-flow oxygen.
Treat if symptomatic, significant level, or high-risk comorbidity.
Disposition:
Observe until symptoms and methemoglobin improve.
Admit if severe, recurrent, or due to long-acting agent like dapsone.

Classic Presentation

A 24-year-old undergoes a dental procedure with benzocaine spray and then becomes cyanotic and short of breath. Pulse ox reads 85% despite 100% oxygen, but the ABG shows a normal PaO2. Co-oximetry reveals methemoglobin of 28%. He receives methylene blue and rapidly improves.

Study Directive

Draw the oxygen dissociation/measurement mismatch that creates the saturation gap.
Memorize methylene blue dose and the key caution with G6PD deficiency.
Review common triggers: benzocaine, dapsone, nitrates.
Practice recognizing when a cyanotic patient is “too well-looking” for severe hypoxemia.
Compare methemoglobinemia vs carboxyhemoglobinemia in a one-page note.

Key Medications

Methylene blue
1–2 mg/kg IV over 5 minutes; may repeat once after 30–60 minutes if needed.
Use with caution in G6PD deficiency; efficacy may be reduced and hemolysis risk exists.
Avoid high cumulative dosing unless directed by toxicology.
Ascorbic acid
Sometimes used when methylene blue is contraindicated, but onset is slower and evidence is weaker; dosing varies—check protocol.
Exchange transfusion / hyperbaric oxygen
Rare rescue options in refractory severe cases.

High-Yield Pearls

Think of a “saturation gap”: low pulse ox, normal PaO2.
Pulse ox often hovers near 85% in methemoglobinemia regardless of oxygen administration.
Methylene blue requires NADPH-dependent reduction, so it may be less effective in G6PD deficiency.

Board Question

A patient develops cyanosis after using benzocaine spray. Pulse oximetry remains at 85% despite oxygen, and ABG shows normal PaO2. Which test confirms the diagnosis?

AD-dimer
BCo-oximetry
CSerum lactate only
DV/Q scan

Reveal answer

Correct: B

Co-oximetry Methemoglobinemia is diagnosed by measuring abnormal hemoglobin species on co-oximetry. Standard pulse oximetry can be misleading, and ABG PaO2 can remain normal because the dissolved oxygen content is preserved.

4 of 5

Pediatric Concerns in Poisoning

Pediatric poisonings often present differently than adult ingestions, and toddlers are vulnerable to rapid decompensation from small amounts of high-risk...

At the Bedside

Two major categories:
Unintentional exploratory ingestions in toddlers.
Intentional self-harm in adolescents.
High-risk pediatric toxins:
Iron: severe GI injury, shock, metabolic acidosis, liver failure.
Button batteries: esophageal liquefaction necrosis within hours.
Magnets: bowel entrapment/fistula if multiple.
Household opioids, clonidine, beta-blockers, calcium channel blockers, cannabis edibles.
Hydrocarbons: aspiration risk.
Caustics: airway/GI burns.
Evaluation:
Vital signs, glucose, mental status, pupil size, respiratory effort.
Targeted history: substance, formulation, dose, time, weight, access, co-ingestants.
Poison center consultation early.
ECG for unknown ingestion, bradycardia, or concern for cardiotoxic drugs.
Consider acetaminophen and salicylate levels in intentional/unclear ingestions.
Management:
ABCs first; secure airway if depressed mental status or aspiration risk.
Immediate POC glucose in any altered child.
Decontamination only when appropriate and safe.
Use specific antidotes when indicated: naloxone, glucagon, calcium, insulin/glucose, digoxin Fab, octreotide, etc.
Disposition:
Observe asymptomatic children based on toxin, timing, and poison center guidance.
Admit for symptomatic exposures, sustained-release products, high-risk ingestions, or unsafe home situations.
In any concern for neglect, abuse, or intentional poisoning, involve social work/child protection.

Classic Presentation

A 2-year-old is brought in after being found with an open grandmother’s pill organizer. He is sleepy and diaphoretic with a glucose of 41 mg/dL. The ECG is normal, but the ingestion history is unclear. After IV dextrose, he is monitored closely for recurrent hypoglycemia, and the family is counseled on safe storage while poison center assists with risk stratification.

Study Directive

Make a pediatric poisoning “must-not-miss” list: iron, button battery, magnets, opioids, caustics, clonidine.
Memorize pediatric antidote starting doses for naloxone, dextrose, and octreotide.
Practice a 30-second history for caregiver interview: substance, access, time, amount, formulation.
Review when to call poison center and when to escalate to child protection.
Draw the algorithm for the lethargic toddler: glucose first, then tox-specific workup.

Key Medications

Naloxone
Pediatric: 0.1 mg/kg IV/IM/IN initially; may use 0.4–2 mg depending on scenario.
Activated charcoal
1 g/kg PO/NG up to adult dose if appropriate, early, and airway protected.
Dextrose
D10W 2.5 mL/kg IV for pediatric hypoglycemia.
Atropine
0.02 mg/kg IV/IM minimum single dose commonly 0.1 mg, max 0.5 mg child / 1 mg adolescent in many protocols; verify local pediatric resuscitation dosing.
Octreotide
Often 1–2 mcg/kg/dose for sulfonylurea toxicity; verify local protocol.
Calcium, glucagon, insulin, sodium bicarbonate
Doses vary by toxin and severity; use pediatric poison center guidance.

High-Yield Pearls

In pediatrics, hypoglycemia is a diagnosis you must actively check in any altered child.
Button batteries in the esophagus are a time-critical emergency, not a “watch and wait” finding.
Multiple magnets can create pressure necrosis and fistulas even if the child looks well initially.

Board Question

A 15-month-old is drooling and refusing to eat after a suspected household ingestion. X-ray shows a round radiopaque object lodged in the esophagus. What is the next best step?

AObserve overnight only
BGive activated charcoal
CUrgent endoscopic removal
DInduce vomiting

Reveal answer

Correct: C

Urgent endoscopic removal An esophageal button battery or impacted foreign body requires urgent removal because tissue injury can occur quickly. Activated charcoal and emesis are inappropriate and potentially harmful.

5 of 5

Pesticides and Cholinergic Toxicity and Poisoning

Organophosphate and carbamate poisoning can cause rapid respiratory failure from bronchorrhea, bronchospasm, and paralysis. Early atropinization and...

At the Bedside

Cholinergic toxidrome: salivation, lacrimation, urination, defecation, GI cramping, emesis, miosis, bradycardia, bronchorrhea, bronchospasm, diaphoresis, fasciculations, weakness, seizures.
Exposures: organophosphate insecticides, carbamates, nerve agents, contaminated clothing/skin, contaminated food.
Workup:
Primarily clinical; do not delay treatment for labs.
ECG, ABG/VBG if respiratory distress, CXR if aspiration/pulmonary edema suspected.
Cholinesterase levels can support diagnosis but are not needed for initial care.
Initial management:
Decontaminate immediately: remove clothing, wash skin thoroughly, protect staff with PPE.
Airway suctioning and oxygen; intubate early if severe secretions/respiratory failure.
Continuous cardiac and respiratory monitoring.
Definitive therapy:
Atropine to dry secretions and reverse bronchospasm/bradycardia.
Pralidoxime (2-PAM) for organophosphates to reactivate acetylcholinesterase, especially if nicotinic weakness/paralysis or significant exposure; best early.
Benzodiazepines for seizures.
Disposition:
ICU for any significant symptomatic exposure, ventilatory need, or pralidoxime requirement.
Observe only mild, resolving cases after poison center input.

Classic Presentation

A farm worker is brought in with profuse salivation, pinpoint pupils, wheezing, bradycardia, and muscle fasciculations after pesticide exposure. He is immediately decontaminated, suctioned, and given repeated atropine boluses until secretions improve, followed by pralidoxime for presumed organophosphate poisoning. He is admitted to the ICU for respiratory monitoring.

Study Directive

Memorize the cholinergic toxidrome and be able to list muscarinic vs nicotinic signs separately.
Practice atropine titration conceptually: “double every few minutes until secretions dry.”
Review PPE and decontamination steps before touching a contaminated patient.
Draw the AChE inhibition pathway and where atropine vs pralidoxime act.
Rehearse an ICU escalation plan for a patient with secretions plus weakness.

---

Mechanism Pearl of the Day: Several toxins today cause emergency by disrupting oxygen delivery at different levels: digoxin and pesticides impair membrane ion handling and conduction, hypoglycemics deprive the brain of substrate, and methemoglobinemia reduces hemoglobin’s ability to carry usable oxygen. In each, the bedside clue is often physiology mismatch: the patient looks sicker than a single number explains.

Key Medications

Atropine
Adult: 1–3 mg IV, then double every 3–5 min until bronchial secretions dry and oxygenation/ventilation improve.
There is major variability and severe cases may require very large cumulative doses; titrate to effect and follow toxicology guidance.
Pralidoxime (2-PAM)
Adult: 1–2 g IV over 15–30 min, may repeat or infuse depending on protocol and severity.
Alternative adult infusion regimens vary significantly; check poison center/institutional protocol.
Pediatric dosing commonly 20–50 mg/kg IV (max per protocol); verify local guidance.
Diazepam
5–10 mg IV for seizures/agitation.
Lorazepam
2–4 mg IV for seizures.
Activated charcoal
Not routine; only if specific ingestion and airway protected, and poison center recommends.

High-Yield Pearls

Atropine dries, pralidoxime reverses enzyme inhibition.
Bronchorrhea and bronchospasm are the immediate life threats—airway control is often the first priority.
Carbamates can look the same as organophosphates clinically, but pralidoxime benefit is less certain; toxicology guidance matters.

Board Question

A man exposed to an agricultural insecticide presents with miosis, bronchorrhea, bradycardia, and fasciculations. Which medication directly helps regenerate acetylcholinesterase in organophosphate poisoning?

AAtropine
BPralidoxime
CNaloxone
DFlumazenil

Reveal answer

Correct: B

Pralidoxime Pralidoxime reactivates acetylcholinesterase if given early enough in organophosphate poisoning, particularly for nicotinic weakness and paralysis. Atropine treats muscarinic symptoms but does not restore enzyme function.

TheDaily Differential

Digoxin Toxicity and Poisoning

At the Bedside

Study Directive

More in Today's Issue

Hypoglycemic Agents Toxicity and Poisoning

At the Bedside

Study Directive

Key Medications

High-Yield Pearls

Methemoglobinemia

At the Bedside

Study Directive

Key Medications

High-Yield Pearls

Pediatric Concerns in Poisoning

At the Bedside

Study Directive

Key Medications

High-Yield Pearls

Pesticides and Cholinergic Toxicity and Poisoning

At the Bedside

Study Directive

Key Medications

High-Yield Pearls

Journal Watch

Clinical Conundrum: What Is the Role of TXA in Dysfunctional Uterine Bleeding?

Podcast Pick

Case of the Day